RVTY's Vital Signs: Strong Pulse, Fat Premium on Healthcare Play
Healthcare diagnostics don't make for flashy headlines, but they make for steady profits. Revvity's Q1 earnings beat shows exactly why we're selling the $90 put for $2.67 — that's a 3.0% return over 4
Atlas Portfolio results referenced in this post are produced in a simulation environment using EOD market data and contract pricing. They are not records of trades placed in a brokerage account or executed with real capital, and individual results would vary based on fills, commissions, slippage, and account size. Tiblio is a software platform for finding and executing options trade ideas. We are not a registered investment advisor or broker-dealer. Nothing in this post is financial advice. Options trading involves substantial risk of loss. Past or simulated performance does not guarantee future results.